Ruihua Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ruihua Liu has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Chunyan Yi
Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, 58th, Zhongshan Road II, Guangzhou 510080, China
2 shared publications - Haiping Mao
Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
2 shared publications - Haishan Wu
Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, 58th Zhongshan Road II, Guangzhou 510080, China
2 shared publications - Jianxiong Lin
Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, Guangdong, China; NHC Key Laboratory of Clinical Nephrology (Sun Yat-Sen University) and Guangdong Provincial Key Laboratory of Nephrology, Guangzhou 510080, Guangdong, China
2 shared publications - Jing Guo
Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, 58th Zhongshan Road II, Guangzhou 510080, China
2 shared publications - Shiyan Tu
Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, 58th Zhongshan Road II, Guangzhou 510080, China
2 shared publications
Latest Publications
- Open Access
- 16 July 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (14) , 5030
Association Between Atherogenic Index of Plasma and Clinical Outcomes in Peritoneal Dialysis Population
Background: The atherogenic index of plasma (AIP), a prognostic indicator for cardiovascular disease, has not been fully explored in relation to clinical outcomes in patients receiving peritoneal dialysis. This study aims to elucidate the relationship between baseline AIP levels and all-cause mortality, cardiovascular mortality, and the peritonitis risk in this population. Methods: This retrospective cohort study included incident peritoneal dialysis patients in our center from 1 January 2006 through 31 December 2021. The end of the follow-up time was 31 December 2023. The participants were stratified by baseline AIP levels. Kaplan–Meier curves, Cox regression analyses, and subgroup analyses were used to evaluate associations with clinical outcomes. Results: The average age of the 2460 participants in this study was 45.9 years, and 1456 (59.2%) of them were men. Diabetic nephropathy (19.5%) was the second most common kidney disease, after primary glomerulonephritis (60.8%). The higher AIP tertile group was significantly associated with increased risks of all-cause mortality, cardiovascular mortality, and peritonitis compared to the lowest AIP group, as evidenced by the Kaplan–Meier curves and the multivariate analyses. Continuous AIP levels also showed a positive correlation with the all-cause mortality and peritonitis risk, even after controlling for covariates. Conclusions: Our study highlights AIP as a predictive marker for adverse outcomes in PD patients, emphasizing its potential utility in risk stratification and clinical management.
- 16 July 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (14) , 5030
Open AccessAssociation Between Atherogenic Index of Plasma and Clinical Outcomes in Peritoneal Dialysis Population
Background: The atherogenic index of plasma (AIP), a prognostic indicator for cardiovascular disease, has not been fully explored in relation to clinical outcomes in patients receiving peritoneal dialysis. This study aims to elucidate the relationship between baseline AIP levels and all-cause mortality, cardiovascular mortality, and the peritonitis risk in this population. Methods: This retrospective cohort study included incident peritoneal dialysis patients in our center from 1 January 2006 through 31 December 2021. The end of the follow-up time was 31 December 2023. The participants were stratified by baseline AIP levels. Kaplan–Meier curves, Cox regression analyses, and subgroup analyses were used to evaluate associations with clinical outcomes. Results: The average age of the 2460 participants in this study was 45.9 years, and 1456 (59.2%) of them were men. Diabetic nephropathy (19.5%) was the second most common kidney disease, after primary glomerulonephritis (60.8%). The higher AIP tertile group was significantly associated with increased risks of all-cause mortality, cardiovascular mortality, and peritonitis compared to the lowest AIP group, as evidenced by the Kaplan–Meier curves and the multivariate analyses. Continuous AIP levels also showed a positive correlation with the all-cause mortality and peritonitis risk, even after controlling for covariates. Conclusions: Our study highlights AIP as a predictive marker for adverse outcomes in PD patients, emphasizing its potential utility in risk stratification and clinical management.
- Open Access
- 9 May 2025
- Published by MDPI AG in Preprints.org
The Association Between Atherogenic Index of Plasma and Clinical Outcomes in Peritoneal Dialysis Population
Background The atherogenic index of plasma (AIP), a prognostic indicator for cardiovascular disease, has been underexplored in relation to clinical outcomes in patients receiving peritoneal dialysis. This study aims to elucidate the relationship between baseline AIP levels and all-cause mortality, cardiovascular mortality, and peritonitis risk in this population. Methods This retrospective cohort study included incident peritoneal dialysis patients in our center from 1 January 2006 through 31 December 2021. The end of follow-up time was 31 December 2023. Participants were stratified by baseline AIP levels. Kaplan-Meier curves, Cox regression analysis, and subgroup analysis were used to evaluate associations with clinical outcomes. Results The average age of the 2,460 participants in this study was 45.9 years, and 1,456 (59.2%) of them were men. Diabetic nephropathy (19.5%) was the second most common kidney disease, after primary glomerulonephritis (60.8%). The higher AIP tertile group was statistically associated with increased risks of all-cause mortality, cardiovascular mortality, and peritonitis compared to the lowest AIP group, as evidenced by Kaplan-Meier curves and multivariate analyses. Continuous AIP levels also showed a positive correlation with all-cause mortality risk, even after controlling for covariates. Conclusion Our study highlights AIP as a predictive marker for adverse outcomes in PD patients, emphasizing its potential utility in risk stratification and clinical management.
- 9 May 2025
- Published by MDPI AG in Preprints.org
Open AccessThe Association Between Atherogenic Index of Plasma and Clinical Outcomes in Peritoneal Dialysis Population
Background The atherogenic index of plasma (AIP), a prognostic indicator for cardiovascular disease, has been underexplored in relation to clinical outcomes in patients receiving peritoneal dialysis. This study aims to elucidate the relationship between baseline AIP levels and all-cause mortality, cardiovascular mortality, and peritonitis risk in this population. Methods This retrospective cohort study included incident peritoneal dialysis patients in our center from 1 January 2006 through 31 December 2021. The end of follow-up time was 31 December 2023. Participants were stratified by baseline AIP levels. Kaplan-Meier curves, Cox regression analysis, and subgroup analysis were used to evaluate associations with clinical outcomes. Results The average age of the 2,460 participants in this study was 45.9 years, and 1,456 (59.2%) of them were men. Diabetic nephropathy (19.5%) was the second most common kidney disease, after primary glomerulonephritis (60.8%). The higher AIP tertile group was statistically associated with increased risks of all-cause mortality, cardiovascular mortality, and peritonitis compared to the lowest AIP group, as evidenced by Kaplan-Meier curves and multivariate analyses. Continuous AIP levels also showed a positive correlation with all-cause mortality risk, even after controlling for covariates. Conclusion Our study highlights AIP as a predictive marker for adverse outcomes in PD patients, emphasizing its potential utility in risk stratification and clinical management.